5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-3-[2-(5-ethylpyridin-2-yl)ethyl]-1,3-thiazolidine-2,4-dione


Chemical Name: 5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-3-[2-(5-ethylpyridin-2-yl)ethyl]-1,3-thiazolidine-2,4-dione
CAS Number: 952188-00-0
Product Number: AG00667N(AGN-PC-01LV7Z)
Synonyms:
MDL No:
Molecular Formula: C28H31N3O3S
Molecular Weight: 489.6290

Identification/Properties


Properties
MP:
85-87°C
Storage:
-10 ℃;
Form:
Solid
Computed Properties
Molecular Weight:
489.634g/mol
XLogP3:
5.7
Hydrogen Bond Donor Count:
0
Hydrogen Bond Acceptor Count:
6
Rotatable Bond Count:
11
Exact Mass:
489.209g/mol
Monoisotopic Mass:
489.209g/mol
Topological Polar Surface Area:
97.7A^2
Heavy Atom Count:
35
Formal Charge:
0
Complexity:
684
Isotope Atom Count:
0
Defined Atom Stereocenter Count:
0
Undefined Atom Stereocenter Count:
1
Defined Bond Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Covalently-Bonded Unit Count:
1
Compound Is Canonicalized:
Yes

Safety Information


NMR Spectrum


Other Analytical Data


Request for Quotation


Customer Feedback


Chemical Structure



PIOGLITAZONE EP IMPURITY C is a crucial component used in chemical synthesis processes. This specialized impurity is employed in the synthesis of Pioglitazone, a medication primarily used to treat type 2 diabetes. By integrating PIOGLITAZONE EP IMPURITY C into the synthesis process, chemists can ensure the creation of high-quality Pioglitazone that meets stringent regulatory standards. This impurity plays a key role in the precise and controlled synthesis of Pioglitazone, enhancing the efficiency and reliability of the manufacturing process.